How whole-genome sequencing can quickly detect TB drug resistance—and help India wipe out TB in the next two years
Experts agree that next-generation sequencing is the best weapon for comprehensively tracking multi-drug-resistant TB
A new exome-based test will help determine the genetic variants—germline and somatic—driving these rare cancers
Data from this international partnership will assist biologists in protecting the herds they study
On Rare Disease Day 2023, Illumina spotlights four patient organizations and accelerates iHope
| Date | Publication | Title |
|---|---|---|
| 20 Mar. 2023 | CNN International | 100,000 newborn babies will have their genomes sequenced in the UK. It could have big implications for child medicine |
| 14 Mar. 2023 | TechnologieBox | CeGaT is one of the first companies worldwide to receive the most powerful sequencing platform NovaSeq™ X Plus |
| 8 Mar. 2023 | Diagnostics World | Illumina, Myriad Partner To Release HRD Test |
| 6 Mar. 2023 | Korea Biomedical Review | Macrogen installs Illumina’s latest production-scale sequencer |
| 22 Feb. 2023 | Savoy Network | Illumina: Expanding the DEI Blueprint to Drive Change |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
